DG
SNY icon

Doman Group’s Sanofi SNY Stock Holding History

Doman Group’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$1.36M Buy
+27,061
New +$1.34M 1.19% 38

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Doman Group's SNY Position: Q4 2021 in Review

Doman Group opened a new position in Sanofi (SNY) in Q4 2021: 27,061 shares worth $1.36M. The stake represents 1.19% of the portfolio and ranks #38 among its holdings.

624 funds tracked by Wall St. Rank hold SNY as of Q4 2021.

  • Doman Group held 27,061 shares of Sanofi worth $1.36M as of Q4 2021.
  • Sanofi was a new Doman Group position in Q4 2021.
  • Sanofi made up 1.19% of Doman Group's portfolio in Q4 2021, its #38 holding.
  • 624 funds tracked by Wall St. Rank held Sanofi as of Q4 2021.

Based on Doman Group's 13F filing for Q4 2021, filed 14 Mar 2022.